We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TTOO market cap is 5.78M. The company's latest EPS is USD -2.3798 and P/E is -0.11.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.47M | 1.68M | 2.06M | 1.95M | 1.99M |
| Operating Income | -13.61M | -9.32M | -12.6M | -9.58M | -10.16M |
| Net Income | -15.43M | -10.34M | -13.53M | -8.96M | -10.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.34M | 18.13M | 28.06M | 22.31M | 7.19M |
| Operating Income | -52.06M | -41.36M | -42.97M | -55.2M | -49.66M |
| Net Income | -59.01M | -46.79M | -49.24M | -62.33M | -50.08M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 43.28M | 34.8M | 24.76M | 21.72M | 18.08M |
| Total Liabilities | 62.52M | 62.83M | 62.53M | 27.62M | 29.79M |
| Total Equity | -19.24M | -28.04M | -37.77M | -5.9M | -11.71M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.49M | 79.08M | 60.54M | 34.33M | 34.8M |
| Total Liabilities | 62.49M | 70.35M | 73.44M | 73.98M | 62.83M |
| Total Equity | -34.01M | 8.73M | -12.9M | -39.66M | -28.04M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -38.72M | -48.14M | -11.68M | -20.92M | -27.18M |
| Investing | -166k | -192k | N/A | N/A | N/A |
| Financing | 51.88M | 52.69M | 2.2M | 9.48M | 13.57M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -45.36M | -43.22M | -38.87M | -50.63M | -48.14M |
| Investing | -761k | -36.26M | 24.79M | 9.66M | -192k |
| Financing | 6.35M | 85.61M | 20.54M | 29.05M | 52.69M |
| Market Cap | 5.78M |
| Price to Earnings Ratio | -0.11 |
| Price to Sales Ratio | 0.76 |
| Price to Cash Ratio | 0.35 |
| Price to Book Ratio | -0.2 |
| Dividend Yield | - |
| Shares Outstanding | 21.04M |
| Average Volume (1 week) | 899.51k |
| Average Volume (1 Month) | 881.96k |
| 52 Week Change | -93.30% |
| 52 Week High | 6.95 |
| 52 Week Low | 0.25 |
| Spread (Intraday) | 0.03 (11.38%) |
| Company Name | T2 Biosystems Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.t2biosystems.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
